See more : Resverlogix Corp. (RVXCF) Income Statement Analysis – Financial Results
Complete financial analysis of Norbel Baby Co., Ltd (6844.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Norbel Baby Co., Ltd, a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Aspire Global plc (ASPIRE.ST) Income Statement Analysis – Financial Results
- P.M. Telelinnks Limited (PMTELELIN.BO) Income Statement Analysis – Financial Results
- LX International Corp. (001120.KS) Income Statement Analysis – Financial Results
- Cemtrex, Inc. (CETXP) Income Statement Analysis – Financial Results
- Empiric Student Property plc (EPCFF) Income Statement Analysis – Financial Results
Norbel Baby Co., Ltd (6844.TWO)
About Norbel Baby Co., Ltd
Norbel Baby Co., Ltd engages in the maternity and baby care products, medical supplies, dietary supplements, and cosmetics in Taiwan. It also sells its products through franchised stores. The company was founded in 1986 and is based in Kaohsiung, Taiwan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 3.60B | 4.20B | 3.81B | 3.89B | 3.55B | 3.76B |
Cost of Revenue | 2.38B | 2.99B | 2.79B | 2.86B | 2.58B | 2.45B |
Gross Profit | 1.23B | 1.21B | 1.03B | 1.03B | 966.83M | 1.31B |
Gross Profit Ratio | 34.06% | 28.80% | 26.88% | 26.48% | 27.27% | 34.86% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 127.82M | 127.04M | 110.05M | 106.55M | 0.00 | 0.00 |
Selling & Marketing | 850.19M | 846.34M | 791.94M | 771.45M | 0.00 | 0.00 |
SG&A | 978.01M | 759.23M | 697.31M | 683.70M | 644.82M | 864.85M |
Other Expenses | 0.00 | 13.54M | 22.22M | 8.84M | 0.00 | 0.00 |
Operating Expenses | 978.01M | 759.23M | 697.31M | 683.70M | 644.82M | 864.85M |
Cost & Expenses | 3.35B | 3.75B | 3.49B | 3.54B | 3.22B | 3.31B |
Interest Income | 13.57M | 3.88M | 1.69M | 2.51M | 4.59M | 6.00M |
Interest Expense | 16.57M | 15.16M | 16.25M | 16.98M | 15.46M | 2.00K |
Depreciation & Amortization | 225.62M | 214.74M | 204.36M | 195.90M | 196.23M | 24.45M |
EBITDA | 502.39M | 683.43M | 556.02M | 542.28M | 518.23M | 468.90M |
EBITDA Ratio | 13.95% | 15.84% | 13.96% | 13.94% | 14.62% | 12.48% |
Operating Income | 249.00M | 451.26M | 328.13M | 346.38M | 322.00M | 444.45M |
Operating Income Ratio | 6.91% | 10.74% | 8.60% | 8.90% | 9.08% | 11.83% |
Total Other Income/Expenses | 11.20M | 2.26M | 7.27M | -5.63M | -3.58M | 12.25M |
Income Before Tax | 260.20M | 453.52M | 335.40M | 340.75M | 318.43M | 456.71M |
Income Before Tax Ratio | 7.22% | 10.79% | 8.79% | 8.76% | 8.98% | 12.16% |
Income Tax Expense | 52.16M | 90.64M | 71.20M | 71.39M | 72.39M | 100.08M |
Net Income | 208.04M | 362.88M | 264.21M | 269.36M | 246.04M | 356.63M |
Net Income Ratio | 5.78% | 8.63% | 6.93% | 6.92% | 6.94% | 9.49% |
EPS | 6.21 | 12.08 | 8.79 | 8.97 | 8.19 | 11.87 |
EPS Diluted | 6.21 | 12.05 | 8.77 | 8.97 | 8.19 | 11.87 |
Weighted Avg Shares Out | 33.48M | 30.04M | 30.04M | 30.04M | 30.04M | 30.04M |
Weighted Avg Shares Out (Dil) | 33.52M | 30.12M | 30.12M | 30.04M | 30.04M | 30.04M |
Source: https://incomestatements.info
Category: Stock Reports